还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

; R* t& G. B9 K- f+ `- h8 `8 u4 J                               
登录/注册后可看大图

$ E: H6 J) `, o+ A2 W# J5 E请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  

+ N, E9 g- j4 P. p: ]) K+ R
. E, I" \- C  |4 Z& OSub-category:
Molecular Targets

! o& m/ |! J' j
9 H$ Y: b  C, L: a7 V- b% d4 n/ ACategory:
Tumor Biology
" Y) u0 v4 y+ n' A$ }& b/ I9 O

5 C- Y: m2 S8 Q# tMeeting:
6 P2 a  a) N4 O! b5 J8 q! p* d7 O2011 ASCO Annual Meeting
* [. n: M$ H, v1 H6 m- K. f
+ Z! V: w/ y( N+ a0 L4 z4 D
& M5 n6 @, W% @5 @3 j; d$ }Session Type and Session Title:
8 A% Y/ t2 y  G" Y$ K& pPoster Discussion Session, Tumor Biology

7 e) \4 U  S) W* A
Abstract No:
+ N6 L3 C  J( o, t) p9 l9 M10517


Citation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)

, c1 ?; y* F( \8 d& V) n
$ ^7 S" H4 m3 Q, s" JAuthor(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
$ ?" y/ n7 V; F  @) X; `

) s) V( e7 G/ x4 T* c2 z
& i5 _$ j( s/ x8 i( p' s. zAbstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
  M) D: R" S7 n4 I& [' A* y
9 b# j  u) l2 ]( Y9 D% {+ xAbstract Disclosures

Abstract:
$ ^0 W& a# J7 O& u

& v2 m+ h' l; u  m' d7 PBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
" d# e! t0 g9 T- y

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

/ A/ ~% [. I1 B$ B3 `化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

4 {* N* C8 Z" v& u  c- @                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
% _; `7 `: v# I+ aALK一个指标医院要900多 ...

; N" D/ ~8 y* {1 E- p1 h+ n. E平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？

& k" s1 E- b2 J- K, D! K6 @, h现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊